Indication of Adbry (tralokinumab-ldrm) expanded to include patients 12 to 17 years of age with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or for whom those therapies are not advisable. The FDA has approved an expanded indication for LEO Pharma’s Adbry (tralokinumab-ldrm) for patients 12 to 17 years of age […]
As companies continued to expand their DE&I efforts, Pharm Exec was there to cover it in 2023. Equity for Women in Healthcare: 131 Years is Too Long to Wait Closing the gender gap in pharma—and how we get there together. Q&A with Amy West, Head of US Digital Health & Innovation Strategy at Novo Nordisk […]
Pharm Exec spent the year speaking with some of the most interesting professionals from the life sciences industry.
Published on: December 27, 2023 Our top five episodes of the year. The Explosive Arrival of Chat GPT and Generative AIFran Pollaro talks with Faruk Capan is the CEO, EVERSANA INTOUCH & Chief Innovation Officer, EVERSANA about the arrival of Chat GPT and generative AI in the public consciousness. This is just the beginning. Gene Therapies: […]
Pharma marketing teams had to deal with big changes in 2023. Q&A With UCB’s Camille Lee on New Psoriasis Medication Approval The UCB executive speaks on recent FDA approval of Bimzelx. Artificial Intelligence Changing the Landscape for Healthcare Social Media Marketing Experts from Hootsuite noted that the primary social media ROI concern for healthcare companies […]
Five trends in pharmaceutical marketing from the past year. Doctors as influencers A recent Hootsuite social trends presentation focused on healthcare revealed that a significant majority of Gen Z use social media platforms like TikTok and LinkedIn to look up health-related information. Using a mix of medical, personal, and trendy posts—doctors on TikTok have gained […]
As this exciting technology exploded in 2023, Pharm Exec was there to cover it all. The Promise and Challenges of Generative AI in Healthcare Pharma industry stakeholders must develop actionable roadmaps to prioritize the areas in which the use of generative artificial intelligence can create the greatest benefits. Embracing AI: Q&A with Shalu Chadha Accenture’s […]
Enabling Authenticity Natalie Bickford, chief people officer at Sanofi, reveals how she approaches the employee experience, which ultimately influences employee retention, and discusses the importance of a corporate DE&I strategy in those efforts. Built for the Moment Starting out with limited pharma business knowledge, how the lessons learned and realizations made helped to forge a […]
Filsuvez (birch triterpenes) is indicated to treat partial thickness wounds associated with junctional epidermolysis bullosa and dystrophic epidermolysis bullosa. The FDA has approved Chiesi Global Rare Diseases’ topical gel Filsuvez (birch triterpenes) to treat partial thickness wounds associated with junctional epidermolysis bullosa (JEB) and dystrophic epidermolysis bullosa (DEB). The regulatory action makes Filsuvez the first […]
Garadacimab is a novel, first-in-class, recombinant monoclonal antibody for hereditary angioedema that targets activated Factor XII. The FDA has accepted a Biologics License Application (BLA) for CSL Behring’s garadacimab (CSL312), a once-monthly prophylactic therapy for hereditary angioedema (HAE). A Marketing Authorization Application (MAA) filed by CSL Behring was also accepted by the European Medicines Agency […]
Published on: December 21, 2023 Explore the implementation of enterprise laboratory software and the start of a digital transformation in your lab with an industry expert who discusses maximizing returns on investment, upholding data integrity while managing cost containment, and adopting digital best practices. This podcast addresses critical topics such as cybersecurity, regulatory compliance and fiscal […]
In a recent article published by Oxford Academic, authors discussed a number of ways that artificial intelligence (AI) and machine learning (ML) could transform biomedical research and healthcare. This includes enhancing operational efficiency, reducing costs, improving diagnostics, identifying therapeutic targets, and enabling personalized treatment. Despite these opportunities, challenges, such as responsible and ethical implementation, workforce […]
Published on: December 21, 2023 Explore the implementation of enterprise laboratory software and the start of a digital transformation in your lab with an industry expert who discusses maximizing returns on investment, upholding data integrity while managing cost containment, and adopting digital best practices. This podcast addresses critical topics such as cybersecurity, regulatory compliance and fiscal […]
American Heart Association survey suggests holiday stress has a major impact on health habits. A recent survey released by the American Heart Association revealed that 79% of respondents tend to neglect their health needs during the holidays, focusing instead on creating special moments for others. Additionally, 51% of Americans state that they take weeks to […]
Data will continue to grow in importance in 2024. Many of the biggest stories in 2023 were related to technological advancements in the life sciences industry. These advancements have increased the importance of having high-quality data. Christoph Bug, vice president of global medical at Veeva, spoke with Pharmaceutical Executive about the trends he sees coming […]
If approved by the FDA, Xolair would be the first drug indicated to lower allergic reactions to multiple foods after an accidental exposure, including peanut, milk, and egg allergies. The FDA has granted Priority Review to Genentech’s supplemental Biologics License Application (sBLA) for Xolair (omalizumab) for the treatment of allergic reactions, such as anaphylaxis, that may result […]
JAMA study aims to discover whether ignoring medical advice relates to financial status among patients with heart failure. Recently published research points to a need for greater outreach efforts to improve medication uptake among underserved patient populations. In a JAMA Network study published last week, the authors set out to discover whether medication nonadherence amongst […]
Merck’s Biologics License Application for V116, a novel 21-valent pneumococcal conjugate vaccine has been given a Prescription Drug User Fee Act (PDUFA) date of June 17, 2024. The FDA has granted priority review to Merck’s Biologics License Application (BLA) for V116, a novel 21-valent pneumococcal conjugate vaccine developed as a single dose for the prevention […]
In the coming year, efficiency and automation will take center stage to maximize constrained resources but balancing sensible financial management with strategic investments will be vital. The breakneck pace of digital transformation spurred by COVID-19 continued to reshape the life sciences landscape in 2023. Rather than a single watershed moment, this year marked an inflection […]
In clinical trials, Padcev (enfortumab vedotin-ejfv) plus Keytruda (pembrolizumab) produced a statistically significant improvement in survival compared to platinum-based chemotherapy alone in patients with locally advanced or metastatic urothelial cancer. The FDA has approved Padcev (enfortumab vedotin-ejfv; Astellas Pharma and Seagen [now owned by Pfizer]) plus Keytruda (pembrolizumab; Merck) for patients with locally advanced or […]